{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:28:12Z","timestamp":1765232892997,"version":"3.44.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.amjms.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T22:59:59Z","timestamp":1589151599000},"page":"199-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Facts, not Fear: Safety of Hydroxychloroquine"],"prefix":"10.1016","volume":"360","author":[{"given":"Drew","family":"Kuraitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Murina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjms.2020.05.003_bib0001","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.amjms.2020.05.003_bib0002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3899\/jrheum.180124","article-title":"Antimalarial-induced cardiomyopathy in systemic lupus erythematosus: as rare as considered?","volume":"46","author":"Tselios","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2020.05.003_bib0003","article-title":"Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine","volume":"2016","author":"O'Laughlin","year":"2016","journal-title":"Case Rep Cardiol"},{"issue":"4","key":"10.1016\/j.amjms.2020.05.003_bib0004","first-page":"545","article-title":"Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus","volume":"36","author":"McGhie","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjms.2020.05.003_bib0005","article-title":"Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society [e-pub ahead of print]","author":"Sapp","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjms.2020.05.003_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.04.024","article-title":"Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review [e-pub ahead of print]","author":"Sharma","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2020.05.003_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/acr.23296","article-title":"Examination of hydroxychloroquine use and hemolytic anemia in G6PDH-deficient patients","volume":"70","author":"Mohammad","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920301762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920301762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:37:08Z","timestamp":1757702228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962920301762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0002962920301762"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2020.05.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facts, not Fear: Safety of Hydroxychloroquine","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}